Company News, Patents

BMS Patents Hydantoin To Reduce Inflammation

Patent No. US 6,710,064 B2: Bristol-Myers Squibb Co., Princeton, NJ, earn-ed a patent for the use of hydantoin as an anti-inflammatory agent.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters